Signaling pathways
-
BA2664 TCO-PEG4-VC-PAB-MMAESummary: TCO-PEG4-VC-PAB-MMAE is part of the antibody coupled active molecule ADC (forADC). -
BA2665 Mal-PEG4-VA-PBDSummary: Mal-PEG4-VA-PBD is an antibody-coupled active molecule. -
BA2667 Mal-PEG2-Gly-Gly-Phe-Gly-ExatecanSummary: Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan is an ADC. -
BA2668 DM4-SMCCSummary: DM4-SMCC is an antibody-coupled active molecule. -
BA2670 MC-DM1Summary: MC-DM1 is formed by linkerMC and toxic molecule DM1 linkage, which can be used to prepare antibody-coupled active molecules. -
BA2671 DBCO-PEG4-VC-PAB-DMEA-PNU-159682Summary: DBCO-PEG4-VC-PAB-DMEA-PNU-159682, an active molecule-coupling consisting of the ADC connector DBCO-PEG4-VC-PAB and the potent ADC cytotoxin DMEA-PNU-159682. -
BA2673 SPP-DM1Summary: SPP-DM1 is part of the antibody-coupled active molecule. -
BA2674 MC-VC-PABC-DNA31Summary: MC-VC-PABC-DNA31 is part of the antibody-coupled active molecule. -
BA2675 Vc-MMADSummary: Vc-MMAD consists of the linker (Val-Cit) and the microtubule inhibitor MMAD. -
BA2676 Val-Ala-PAB-MMAESummary: Val-Ala-PAB-MMAE is a Drug-LinkerConjugatesforADC.

